The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
Several state lawmakers have filed psychedelics-related bills, many of them aimed at exploring access to and potential uses ...
| With budget reconciliation right around the corner, different slices of the healthcare industry have made their views clear on issues like physician pay, ACA subsidies, telehealth flexibilities, ...
Senate Appropriations Committee ranking member Patty Murray, D-Wash., wrote in a statement the NIH policy change amounts to ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
17h
DC Magazine on MSNThe Ultimate Guide to DC's Philanthropic Events 2025From galas to fashion shows, these are the top charity events coming up this year.Queen Latifah has been a regular at The ...
Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...
Hearst Television's National Investigative Unit is learning more about a substance, not considered an opioid, being mixed ...
Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Light “turns certain biological signals on, which has downstream effects for the skin,” said Amit Om, a dermatologist in ...
The U.S. technology company Booz Allen Hamilton has confirmed it has withdrawn as a corporate sponsor for the international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results